NOS2 and colitis: ADI-PEG treatment protects against colitis in 2 distinct phenotypic animal models, BALB/c wildtypes as well as IL-10 deficient mice, presumably due to the attenuation of inflammatory markers such as SAA, suppression of macrophage infiltration, and iNOS expression in colonic tissues.